Group 1 - The company announced the appointment of several non-executive directors, effective from the end of the extraordinary general meeting, including Dr. Chang Zhao Hua, Mr. Bai Teng Tai Si, Mr. Lu Tian Nian, and Ms. Liang Min [1] - Dr. Liu Guo En and Mr. Zhou Jia Hong have been appointed as independent non-executive directors, effective from the end of the extraordinary general meeting [1] - Dr. Chang Zhao Hua will further serve as the chairman of the board, effective from November 25, 2025 [1] Group 2 - The composition of the board committees will change from November 25, 2025, with Mr. Zhou Jia Hong as the chairman of the audit committee [1] - The remuneration and assessment committee will be chaired by Dr. Liu Guo En, with Mr. Zhou Jia Hong and Mr. Lu Tian Nian as members [1] - The nomination committee will be chaired by Mr. Yao Hai Song, with Mr. Zhou Wei Wen and Ms. Liang Min as members [1] - The strategy and development committee will be chaired by Dr. Liu Guo En, with Mr. Bai Teng Tai Si and Dr. He Chao as members [1] - The commercialization committee will be chaired by Mr. Bai Teng Tai Si, with Mr. Chen Chen, Mr. Liu Yu, and Ms. Liang Min as members [1] Group 3 - The company announced that Mr. Sun Hong Bin will no longer serve as the authorized representative under Listing Rule 3.05, with Dr. Chang Zhao Hua replacing him, effective from November 25, 2025 [2]